ondansetron

Generic: ondansetron

Labeler: lifsa drugs llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ondansetron
Generic Name ondansetron
Labeler lifsa drugs llc
Dosage Form TABLET, ORALLY DISINTEGRATING
Routes
ORAL
Active Ingredients

ondansetron 16 mg/1

Manufacturer
Lifsa Drugs LLC

Identifiers & Regulatory

Product NDC 72336-073
Product ID 72336-073_1540d100-da32-4a84-98d9-a9088d2628ea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077406
Listing Expiration 2026-12-31
Marketing Start 2006-12-26

Pharmacologic Class

Established (EPC)
serotonin-3 receptor antagonist [epc]
Mechanism of Action
serotonin 3 receptor antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72336073
Hyphenated Format 72336-073

Supplemental Identifiers

RxCUI
2685489
UPC
0372336073301
UNII
4AF302ESOS
NUI
N0000175817 N0000175818

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ondansetron (source: ndc)
Generic Name ondansetron (source: ndc)
Application Number ANDA077406 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 16 mg/1
source: ndc
Packaging
  • 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)
source: ndc

Packages (1)

72336-073-30 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)

Ingredients (1)

ondansetron (16 mg/1)

Linked Drug Pages (1)

Ondansetron ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "1540d100-da32-4a84-98d9-a9088d2628ea", "openfda": {"nui": ["N0000175817", "N0000175818"], "upc": ["0372336073301"], "unii": ["4AF302ESOS"], "rxcui": ["2685489"], "spl_set_id": ["c66d63cf-a0e5-4cb5-bdf8-9d1115cba23e"], "pharm_class_epc": ["Serotonin-3 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Serotonin 3 Receptor Antagonists [MoA]"], "manufacturer_name": ["Lifsa Drugs LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)", "package_ndc": "72336-073-30", "marketing_start_date": "20240620"}], "brand_name": "Ondansetron", "product_id": "72336-073_1540d100-da32-4a84-98d9-a9088d2628ea", "dosage_form": "TABLET, ORALLY DISINTEGRATING", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "72336-073", "generic_name": "Ondansetron", "labeler_name": "Lifsa Drugs LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ondansetron", "active_ingredients": [{"name": "ONDANSETRON", "strength": "16 mg/1"}], "application_number": "ANDA077406", "marketing_category": "ANDA", "marketing_start_date": "20061226", "listing_expiration_date": "20261231"}